PDB ID or protein name

Designed proteins (70 proteins)

Family Protein Name PDB ID Localization Num. Subunits Num. TM Sec. Structs. Hydrophobic Thickness or Depth (Å) Tilt Angle (°) ΔGtransfer (kcal/mol)
1.3.01.01. Transmembrane beta-barrel platform protein 2jmm Undefined 1 8 23.9 ± 1.3 4 ± 4 -32.3
2.2.34.11. Kalata B1, all-D analogue 2jue Undefined 1 0 3.7 ± 1.0 82 ± 17 -5.5
2.2.34.11. Melanocortin agonist based on kalata-B1 2lur Undefined 1 0 6.5 ± 1.0 74 ± 21 -6.7
2.2.41.01. Chimeric beta-defensin 2/3 2lxo Undefined 1 0 3.6 ± 0.8 56 ± 14 -5.6
2.4.11.01. Crambin, enantiomer 3ue7 Undefined 1 0 3.4 ± 1.7 89 ± 13 -4.6
3.1.02.01. Fourth intracellular loop of CB1 cannabinoid receptor 2mz2 Eukaryo. plasma 1 0 6.3 ± 1.2 80 ± 6 -7.4
3.1.03.03. Anticancer peptide designed based on the helix of phosphotransferase IIA 1vm2 Undefined 1 0 7.0 ± 1.8 78 ± 15 -12.0
3.1.05.01. Antimicrobial peptide RP-1 2rlg Undefined 1 0 5.9 ± 4.2 75 ± 4 -5.0
3.1.05.02. Self-assembling lipopeptide detergent 3cay Undefined 2 0 14.5 ± 1.3 78 ± 9 -16.4
3.1.05.03. Human platelet factor 4 based peptide, 56-70, modified 1djf Undefined 1 0 1.9 ± 1.4 87 ± 8 -4.9
3.1.05.03. VG16KRKP peptide, structure 1 2mxh Undefined 1 0 2.5 ± 2.4 82 ± 11 -3.2
3.1.05.03. Antimicrobial peptide PaDBS1R1 2n9r Undefined 1 0 5.6 ± 1.0 83 ± 6 -8.3
3.1.05.03. Glycosaminoglycan-binding (KYE) peptide 2ncw Undefined 1 0 5.0 ± 0.4 84 ± 6 -10.1
3.1.05.03. LAK160-P12 2l9a Undefined 1 0 4.9 ± 3.1 87 ± 1 -6.7
3.1.05.03. VG16KRKP peptide, structure 2 2n63 Undefined 1 0 2.5 ± 0.3 57 ± 4 -4.0
3.1.05.03. Lavracin 2n8d Undefined 1 0 5.1 ± 1.2 89 ± 13 -5.7
3.1.05.03. GLFDIVKKVVGALG 5mxl Undefined 1 0 5.0 ± 0.4 86 ± 6 -7.8
3.1.05.03. Peptide YW12 2o0s Bact. Gram-pos cell wall 1 0 3.4 ± 1.3 82 ± 5 -5.5
3.1.05.03. LAK160-P10 2l99 Undefined 1 0 3.9 ± 2.6 84 ± 0 -5.0
3.1.05.03. LAK160-P7 2l96 Undefined 1 0 1.4 ± 0.9 88 ± 5 -2.7
3.1.05.03. Peptide F 1pef Undefined 1 0 6.6 ± 1.3 85 ± 10 -7.8
3.1.05.03. WYHRLSHLHSRLQD 5mxt Undefined 1 0 5.0 ± 0.8 77 ± 10 -6.3
3.1.05.04. Distinctin 1xkm Undefined 2 0 3.9 ± 0.4 87 ± 2 -4.6
3.1.05.05. Anticoccidial peptide PW2 2jq2 Undefined 1 0 6.2 ± 2.3 67 ± 36 -4.5
3.1.05.06. Transportan 1smz Undefined 1 0 9.1 ± 0.8 87 ± 7 -8.9
3.1.05.07. Penetratin 1omq Undefined 1 0 3.2 ± 1.0 79 ± 7 -7.4
3.1.05.08. MSI-594 derived peptide MSI-594-F5A 2l36 Undefined 1 0 6.9 ± 7.0 79 ± 3 -8.3
3.1.05.09. Histidine-rich peptide LAH4 2kjn Undefined 1 0 10.5 ± 6.3 89 ± 2 -10.2
3.1.05.10. WALP19 - Pro8 peptide 2lco Undefined 1 0 9.0 ± 0.4 85 ± 4 -15.0
3.1.05.10. WALP19 - Pro10 peptide 2lcn Undefined 1 1 29.6 ± 6.6 15 ± 7 -12.5
3.1.05.11. ALPS-23 peptide 2m0w Undefined 1 0 5.7 ± 0.5 72 ± 6 -9.4
3.1.05.12. Designed transmembrane metallotransporter 4p6j Undefined 2 2 22.8 ± 2.0 3 ± 1 -21.9
3.1.05.13. Cullin3-derived peptides 2myl Undefined 1 0 3.4 ± 1.2 82 ± 21 -4.4
3.1.06.02. Class A amphipathic helical peptide 2fq5 Undefined 1 0 6.5 ± 1.4 78 ± 6 -8.8
3.1.06.02. Amphipathic alpha-helix of apolipoprotein 2irg Undefined 1 0 6.4 ± 1.7 83 ± 15 -12.1
3.1.11.02. Exendin-4-conotoxin chimera 2naw Secreted 1 0 4.3 ± 1.4 69 ± 8 -2.7
3.1.11.02. Glucagon-like peptide-1 receptor agonists 2n08 Undefined 1 0 6.3 ± 1.3 45 ± 10 -5.4
3.1.21.01. Cecropin (1-7)-melittin (2-9) hybrid 2jmy Undefined 1 0 6.5 ± 3.3 77 ± 7 -6.1
3.1.28.05. Aurein 1.2 analogue 2f3a Undefined 1 0 3.0 ± 1.6 88 ± 24 -11.7
3.1.28.06. Magainin 2, Ala-analogue 4mgp Secreted 1 0 10.0 ± 4.1 79 ± 2 -15.1
3.1.28.06. Magainin analogue 2 5cgo Undefined 2 0 3.8 ± 0.9 89 ± 2 -10.8
3.1.28.06. Magainin analogue, MSI-594 2k98 Undefined 1 0 3.2 ± 0.2 86 ± 2 -8.9
3.1.28.06. Magainin analogue 1 5cgn Undefined 2 0 6.1 ± 2.7 88 ± 6 -14.0
3.1.29.01. Retro KR-12 2nal Undefined 1 0 3.7 ± 0.5 83 ± 5 -6.1
3.1.29.01. LL-37-derived peptide 2l5m Undefined 1 0 6.1 ± 1.0 89 ± 7 -9.7
3.1.29.02. Indolicidin, with P->A substitution 1hr1 Undefined 1 0 5.4 ± 4.0 84 ± 9 -8.3
3.2.01.07. Cys-free protegrin analogue 2mq2 Secreted 1 0 1.3 ± 1.1 61 ± 19 -3.5
3.2.01.09. Cyclic beta-hairpin peptide 2m7i Secreted 1 0 2.0 ± 0.5 84 ± 8 -4.1
3.2.01.09. Chignolin 5awl Undefined 1 0 2.6 ± 2.1 77 ± 28 -2.8
3.2.01.09. Peptide PG-989 2n7n Undefined 1 0 6.1 ± 1.4 83 ± 7 -5.5
3.2.01.09. Peptidomimetic TWLKKRRWKKAK-D-Pro-P 2m7j Undefined 1 0 1.0 ± 1.7 75 ± 37 -2.7
3.2.01.09. Peptide PG-990 2n7o Undefined 1 0 7.9 ± 1.6 68 ± 21 -5.6
3.2.01.09. Transthyretin-derived peptide 5hpp Undefined 1 0 2.7 ± 1.6 83 ± 6 -5.2
3.2.05.02. Microcin J25, redesigned, version 2 2mmw Undefined 1 0 2.6 ± 3.5 90 ± 4 -3.7
3.2.05.02. Microcin J25, redesigned, version 1 2mmt Undefined 1 0 3.0 ± 0.9 90 ± 5 -5.2
3.2.08.01. A macrocyclic beta-sheet peptide 4q8d Undefined 2 2 20.8 ± 0.4 10 ± 3 -6.6
3.2.09.01. Octreotide 1soc Undefined 1 0 8.9 ± 1.8 77 ± 21 -7.7
3.2.10.01. PawS derived peptide 6 2lwv Undefined 1 0 6.8 ± 1.1 69 ± 16 -7.3
3.2.10.01. PawS derived peptide 7 2lwu Undefined 1 0 2.0 ± 1.4 81 ± 10 -3.0
3.2.10.01. PawS derived peptide 10 2nb6 Undefined 1 0 9.9 ± 2.0 48 ± 30 -9.1
3.2.10.01. PawS derived peptide 5 2lwt Undefined 1 0 8.1 ± 2.2 55 ± 21 -5.2
3.2.10.01. PawS derived peptide 4 2lws Undefined 1 0 7.5 ± 1.3 37 ± 13 -5.8
3.2.10.01. PawS derived peptide 11 2lwq Undefined 1 0 10.1 ± 1.4 55 ± 22 -9.5
3.2.10.01. PawS derived peptide 9 2nb5 Undefined 1 0 5.6 ± 1.3 79 ± 14 -6.5
3.2.10.01. PawS derived peptide 22 2ndl Undefined 1 0 8.6 ± 2.1 64 ± 9 -5.3
3.2.11.01. Peptide NC_cEE_D1 5kx2 Undefined 1 0 4.9 ± 1.9 70 ± 14 -4.6
3.4.04.03. Tridecaptin A1 2n5y Undefined 1 0 2.1 ± 1.0 89 ± 7 -3.9
3.4.07.01. Antimicrobial cationic cyclic hexapeptide 1qvl Undefined 1 0 4.2 ± 1.6 84 ± 15 -6.8
3.4.07.01. VG16KRKP peptide 2mwl Undefined 1 0 4.4 ± 1.3 79 ± 12 -3.6
3.4.07.02. Compstatin 1a1p Undefined 1 0 3.4 ± 1.9 72 ± 18 -5.6